Omnitura Therapeutics Inc is categorized under Commercial Medical Research in Redwood City, CA and active since 2010.
Omnitura Therapeutics Inc was established in 2010, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Dao at the company’s single location by writing to 303 Twin Dolphin Drive # 600, Redwood City, California CA 94065 or by phoning (650) 627-9455. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Omnitura Therapeutics Inc |
Contact Person: | Jeffrey Dao |
Address: | 303 Twin Dolphin Drive # 600, Redwood City, California 94065 |
Phone Number: | (650) 627-9455 |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Omnitura Therapeutics Inc was started in 2010 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Jeffrey Dao for inquiries that concern Omnitura Therapeutics Inc by calling the company number (650) 627-9455, as your correspondence is most welcome. Additionally, the physical location of the single location of Omnitura Therapeutics Inc can be found at the coordinates 37.52198,-122.258771 as well as the street address 303 Twin Dolphin Drive # 600 in Redwood City, California 94065.
For its online presence, you may visit Omnitura Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.